Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.38% |
| 2 | Healthcare | 7.46% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.11% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Zimmer Biomet
ZBH
$19.3B
| $148M | 0.07% |
1,014,034
-1,747,099
| -63% | -$237M |
|
202
CALL
Amgen
AMGN
$239B
| $147M | 0.07% |
663,800
+163,100
| +33% | +$37.8M |
|
203
Universal Health Services
UHS
$10.4B
| $147M | 0.07% |
932,759
+209,580
| +29% | +$29.2M |
|
204
State Street
STT
$52.1B
| $147M | 0.07% |
2,006,942
+1,155,556
| +136% | +$83.1M |
|
205
PUT
iShares 20+ Year Treasury Bond ETF
TLT
$46.6B
| $147M | 0.07% |
1,425,000
-590,000
| -29% | -$61.2M |
|
206
Western Union
WU
$2.32B
| $146M | 0.07% |
12,489,087
+2,588,604
| +26% | +$29.8M |
|
207
CALL
Alphabet (Google) Class C
GOOG
$4.25T
| $146M | 0.07% |
1,210,600
+306,000
| +34% | +$35.4M |
|
208
Hewlett Packard
HPE
$69.2B
| $146M | 0.07% |
8,701,159
+6,114,558
| +236% | +$93.5M |
|
209
CALL
Visa
V
$712B
| $146M | 0.07% |
615,100
-74,600
| -11% | -$17.1M |
|
210
PUT
Morgan Stanley
MS
$338B
| $146M | 0.07% |
1,710,100
+301,200
| +21% | +$25.8M |
|
211
Datadog
DDOG
$82.5B
| $145M | 0.07% |
1,476,188
+692,853
| +88% | +$57.9M |
|
212
Option Care Health
OPCH
$3.57B
| $145M | 0.07% |
4,453,145
+1,538,897
| +53% | +$46.4M |
|
213
CVS Health
CVS
$118B
| $145M | 0.07% |
2,092,488
-1,624,321
| -44% | -$116M |
|
214
PUT
Chipotle Mexican Grill
CMG
$48B
| $144M | 0.07% |
3,370,000
+575,000
| +21% | +$22.7M |
|
215
lululemon athletica
LULU
$13.8B
| $144M | 0.07% |
380,281
-536,253
| -59% | -$198M |
|
216
Revvity
RVTY
$13.6B
| $144M | 0.07% |
1,208,726
+101,583
| +9% | +$12.5M |
|
217
Thermo Fisher Scientific
TMO
$229B
| $142M | 0.07% |
272,739
+190,278
| +231% | +$103M |
|
218
PUT
Micron Technology
MU
$1.03T
| $142M | 0.07% |
2,251,500
-338,100
| -13% | -$21.7M |
|
219
Edwards Lifesciences
EW
$52.1B
| $141M | 0.07% |
1,497,084
+31,912
| +2% | +$2.77M |
|
|
220
Amgen
AMGN
$239B
| $140M | 0.07% |
632,107
+575,533
| +1,017% | +$134M |
|
221
Targa Resources
TRGP
$62.5B
| $139M | 0.07% |
1,831,612
+260,724
| +17% | +$18.9M |
|
222
Sensata Technologies
ST
$6.11B
| $139M | 0.07% |
3,080,860
-91,694
| -3% | -$4.02M |
|
|
SGEN
223
CALL
DELISTED
Seagen Inc. Common Stock
SGEN
| $139M | 0.07% |
720,100
+713,800
| +11,330% | +$142M |
|
224
ResMed
RMD
$33.6B
| $138M | 0.07% |
+632,015
| New | +$141M |
|
225
Twilio
TWLO
$34B
| $138M | 0.07% |
2,166,326
+1,576,952
| +268% | +$93.1M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander deployed $14B of net new capital in Q2 2023, opening 870 new positions and adding to 2,213 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.